Pharma stocks slip up to 3% as uncertainties loom around Trump tariffs




Pharma stocks fell up to 3% on US tariff fears.
India may lose up to $31bn in exports.
Bajaj Finserv AMC bullish on pharma growth.
Key drivers: CRAMS, Biosecure Act, patent expiries.

Comments